Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Allergan ophthalmic news

    Allergan plc (NYSE:AGN), Dublin, Ireland Business: Ophthalmic Allergan filed suit against Ferrum Ferro Capital in the U.S. District Court for the Central District of California alleging the hedge fund attempted to …

    Published on 6/29/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The Sandoz unit of Novartis requested that the U.S. Court of Appeals for the Federal Circuit (…

    Published on 6/29/2015
  • Bristol-Myers infectious news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Infectious Bristol-Myers said it will discontinue drug discovery in virology and cut about 100 jobs as part of an ongoing R&D reorganization announced in …

    Published on 6/29/2015
  • Medivir neurology news

    Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Neurology Medivir said it will exit the neuropathic pain therapeutic area following adverse findings in non-clinical safety studies of MIV-247. Medivir has …

    Published on 6/29/2015
  • OraSure, U.S. Department of Health and Human Services diagnostic news

    OraSure Technologies Inc. (NASDAQ:OSUR), Bethlehem, Pa. U.S. Department of Health and Human Services, Washington, D.C. Business: Diagnostic HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 6/29/2015
  • Veloxis Pharmaceuticals transplant news

    Veloxis Pharmaceuticals A/S (CSE:VELO), Horsholm, Denmark Business: Transplant The U.S. District Court for the District of Columbia ruled that FDA was correct in granting tentative approval of immunosuppressant Envarsus…

    Published on 6/29/2015
  • Adrenergics, CadheRx Therapeutics, Calporta Therapeutics, GlaxoSmithKline cancer, cardiology, endocrine/metabolic news

    Adrenergics Inc., San Diego, Calif. CadheRx Therapeutics Inc., San Diego, Calif. Calporta Therapeutics Inc., San Diego, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Cancer, Cardiology, …

    Published on 6/22/2015
  • Amarin, Pharmaceutical Research and Manufacturers of America cardiovascular news

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, D.C. Business: Cardiovascular PhRMA and a coalition of pharmas criticized FDAs position on drug …

    Published on 6/22/2015
  • Celladon cardiovascular news

    Celladon Corp. (NASDAQ:CLDN), San Diego, Calif. Business: Cardiovascular Celladons board approved a plan to reduce headcount by about 50% to about 17 to save cash and the company hired Wedbush PacGrow Healthcare to seek…

    Published on 6/22/2015
  • OmniSeq, Roswell Park Cancer Institute diagnostic, functional genomics news

    OmniSeq LLC, Buffalo, N.Y. Roswell Park Cancer Institute, Buffalo, N.Y. Business: Diagnostic, Functional genomics OmniSeq began its spinout from Roswell Park and will immediately begin commercializing its OmniSeq …

    Published on 6/22/2015
  • Sequenom, Roche diagnostic news

    Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic The U.S. Court of Appeals for the Federal Circuit (CAFC) upheld a lower court judgment that U.S. …

    Published on 6/22/2015
  • GlobeImmune infectious news

    GlobeImmune Inc. (NASDAQ:GBIM), Louisville, Colo. Business: Infectious GlobeImmune will cut the majority of its headcount to save cash after GS-4774 missed the primary endpoint in the Phase II GS-US-330-0101 trial to …

    Published on 6/15/2015
  • J&J infectious news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Infectious Johnson & Johnsons Janssen Pharmaceuticals Inc. unit expanded a 2012 IP policy to allow access to pediatric formulations of HIV drug Prezista …

    Published on 6/15/2015
  • Amarin cardiovascular news

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Cardiovascular A judge in the U.S. Federal District Court for the District of Columbia granted Amarins motion for summary judgment in a suit against FDA in …

    Published on 6/8/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. Court of Appeals for the Federal Circuit (CAFC) heard oral arguments from Amgen and …

    Published on 6/8/2015
  • Critical Path Institute, TB Alliance, St. Georges University, WHO infectious news

    Critical Path Institute, Tucson, Ariz. Global Alliance for TB Drug Development, New York, N.Y. St. Georges University, London, U.K. World Health Organization (WHO), Geneva, Switzerland Business: Infectious WHOs Special …

    Published on 6/8/2015
  • Otsuka Pharmaceutical neurology news

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Business: Neurology The U.S. District Court for the District of Maryland granted FDAs motion for summary judgment in a case filed by Otsuka alleging that the agency …

    Published on 6/8/2015
  • Sorrento gene/cell therapy, cancer news

    Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Business: Gene/Cell Therapy, Cancer Sorrento established TNK Therapeutics Inc., a wholly owned subsidiary to develop chimeric antigen receptor tumor-attacking …

    Published on 6/8/2015
  • Acorda, Hayman Capital Management autoimmune news

    Acorda Therapeutics Inc. (NASDAQ:ACOR), Ardsley, N.Y. Hayman Capital Management, Dallas, Texas Business: Autoimmune Acorda responded to an inter partes review (IPR) filed by hedge fund manager Kyle Bass in February …

    Published on 6/1/2015
  • Astellas musculoskeletal, ophthalmic news

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Musculoskeletal, Ophthalmic Astellas released a three-year strategic plan that adds muscle disease and ophthalmology therapeutic areas. The companys innovative …

    Published on 6/1/2015
  • AstraZeneca, Eisai, Shionogi, Takeda, Drugs for Neglected Diseases initiative infectious news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Shionogi & Co. Ltd. (Tokyo:4507), Osaka, Japan Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Drugs for Neglected …

    Published on 6/1/2015
  • Express Scripts cancer news

    Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. Business: Cancer The pharmacy benefit manager said it is in discussions with manufacturers about indication-based pricing for cancer drugs. Under the model, a …

    Published on 6/1/2015
  • Retrophin, Sanofi gastrointestinal news

    Retrophin Inc. (NASDAQ:RTRX), New York, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Gastrointestinal Retrophin sold its rare pediatric disease Priority Review voucher to Sanofi for $245 million. …

    Published on 6/1/2015
  • Takeda endocrine/metabolic news

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Endocrine/Metabolic Takeda agreed to pay $2.4 billion to settle all pending lawsuits filed by individuals who claimed to have been diagnosed with …

    Published on 6/1/2015
  • Teva neurology news

    Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Business: Neurology Teva will pay $1.2 billion to settle a 2008 Federal Trade Commission antitrust suit alleging that Cephalon Inc., which Teva …

    Published on 6/1/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993